Blog Posts in July, 2012
Posted on Jul 31, 2012 By Arnold & Itkin LLP
The Food and Drug Administration (FDA) approved a new weapon in the fight against AIDS on July 16. Known as Truvada, the medication can help prevent people from contracting HIV, the virus that causes ...
Continue reading "FDA Approves Drug to Prevent HIV Infections" »
Posted on Jul 30, 2012 By Arnold & Itkin LLP
Amgen and Johnson & Johnson spent years marketing three injectable Anemia drugs, Epogen, Procrit and Aranesp, to some of the most vulnerable patients in the country, suffering from cancer and ...
Continue reading "Drug Makers Prescribed Dangerous Anemia Drugs to Make Huge Profits" »
Posted on Jul 27, 2012 By Arnold & Itkin LLP
Medical device maker Orthofix has agreed to pay yet another fine to settle allegations of misconduct. The latest, which will set the company back $5.2 million, is over charges that Promeca, an ...
Continue reading "More Fines for Orthofix" »
Posted on Jul 26, 2012 By Arnold & Itkin LLP
The Endocrine Society, the world's largest organization devoted to research on how hormones function, released a statement on June 26 criticizing the Environmental Protection Agency (EPA) and the ...
Continue reading "Medical Society Releases Statement Criticizing FDA Rulings on BPA" »
Posted on Jul 25, 2012 By Arnold & Itkin LLP
Drug manufacturer Hospira has announced the recall of four different injectable cancer drugs because the presence of a defect in their glass vials could result in embedded particles contaminating the ...
Continue reading "Four Different Cancer Drugs Recalled Due to Vial Flaw" »
Posted on Jul 24, 2012 By Arnold & Itkin LLP
With the explosion of apps available for smart phones these days, it is no surprise that there has been a proliferation of systems created for medical uses. While some simply help monitor weight or ...
Continue reading "FDA Says it Won't Review Most Medical Smart Phone Apps" »
Posted on Jul 23, 2012 By Arnold & Itkin LLP
Physicians at the University of Southern California (USC) are making headway on an experimental drug that may reduce the affects that stroke has on the body. If it works, the drug could improve motor ...
Continue reading "Human Trials for Stroke Drug Starting This Summer" »
Posted on Jul 20, 2012 By Arnold & Itkin LLP
According to a study recently published in the Journal of the American Medical Association, 3.4 out of every 1,000 infants born in the U.S. suffered from an addiction to pain killers. That figure, up ...
Continue reading "More Babies Than Ever Born Addicted to Pain Killers" »
Posted on Jul 19, 2012 By Arnold & Itkin LLP
Roche Holding AG, the manufacturers of the now-recalled drug Accutane, were ordered on June 29 to pay $18 million to two individuals who suffered from serious side effects after taking the acne ...
Continue reading "Roche Hit with $18 Million Accutane Verdict" »
Posted on Jul 18, 2012 By Arnold & Itkin LLP
Despite urgings from the nonprofit consumer watchdog group Public Citizen, the Food and Drug Administration (FDA) approved a new weight loss medication on June 27. In studies the drug, which will be ...
Continue reading "FDA Approves Diet Pill Despite Heart Safety Concerns" »
Posted on Jul 17, 2012 By Arnold & Itkin LLP
In 2007, the Food and Drug Administration (FDA) established comprehensive regulations for companies who manufacture, package or store dietary supplement products, and the following year, the agency ...
Continue reading "Manufacturers of Dietary Supplements Struggle to Comply with FDA Regulations" »
Posted on Jul 16, 2012 By Arnold & Itkin LLP
Defects in Covidien Inc.'s Onyx Liquid Embolic System have been linked to nine patient deaths and at least 100 injuries since 2005, the Food and Drug Administration (FDA) announced in an alert on ...
Continue reading "Covidien Brain Device Tied to Nine Deaths Since 2005" »
Posted on Jul 10, 2012 By Arnold & Itkin, LLP
Last year, Takeda Pharmaceuticals made millions of dollars in the United States selling Actos, a widley popular diabetes drug. Since its beginning in 1999, about 10 million people have taken the drug ...
Continue reading "Generic form of Actos Hits the Market this August" »
Posted on Jul 10, 2012 By Arnold & Itkin LLP
Three senior executives noted for fraudulent drug marketing practices while at GlaxoSmithKline (GSK) have since moved on to take high-level positions at some of Europe's leading pharmaceutical ...
Continue reading "A Fresh Start: Cited GSK Execs Now at Helm of Other Top Drug Firms" »
Posted on Jul 10, 2012 By Arnold & Itkin LLP
Philadelphia drug manufacturer GlaxoSmithKline (GSK) has agreed to pay $3 billion to resolve allegations of fraud and failure to report safety data related to its business practices. The allegations ...
Continue reading "GSK Reaches Historical $3 Billion Dollar Settlement over Fraud Charges" »
Posted on Jul 3, 2012 By Houston Drug Injury Lawyer
Vaginal mesh implants, used to treat pelvic prolapse and urinary incontinence in female patients, have now been shown to fail at extraordinarily high rates, causing discomfort and internal damage to ...
Continue reading "Why Vaginal Mesh Implants Fail at such Astounding Rates" »
Posted on Jul 3, 2012 By Houston Injury Lawyer
Pfizer Inc. has revealed in a filing with the U.S. Securities and Exchange Commission that it has already paid $896 million to settle some 6000 lawsuits related to its menopause drug, Prempro. ...
Continue reading "Prempro Settlement Costs Pfizer $896 Million" »
Posted on Jul 2, 2012 By Houston Personal Injury Attorney
Dallas based medical device manufacturer Orthofix Inc. has agreed to pay more than $34 million dollars to the federal government to settle civil and criminal charges stemming from fraudulent claims it ...
Continue reading "Orthofix to pay $34 million Fine in Medicare Fraud Case" »